Clinotech Diagnostics & Pharmaceuticals Inc,

The mission of CLINOTECH is to be one of the most successful Biotech companies not only in Canada but also internationally. Each technology will fill a current need in medical procedure by improving upon an existing technology or device, or by designing a device to serve a need that is clearly defined and acknowledged by medical professionals. Each product shall be priced to appeal to a managed-care market that stresses most competitive and cost effective treatment parameters. Clinotech already develops and market in-vitro diagnostic (IVD) devices through multiple distribution channels in both domestic and more extensively in the international markets. It is currently seeking to expand its corporate identity through potential investors who are interested in joining hands in the growth in this regard. Clinotech has already launched the following major group of products to its current target markets: 1. Fertility Tests: These include Pregnancy and Ovulation diagnostic tests as well as other related tests for fertility. 2. Tumor Markers: These consist of tests for the detection of cancer of various kinds 3. STI Tests: These comprise Sexually Transmitted Infections 4. Infectious Diseases Tests: These include diagnosis for various infectious diseases including the Tropical diseases. 5. Blood Transfusion Tests: These comprise HIV, Syphilis, Hepatitis B and C especially on routine basis. 6. Endocrine: Consists of all major hormone detection tests 7. Urine Chemistry: The routine urine reagent test to screen for diabetic, liver and kidney problems. 8. Drugs of Abuse: Tests for Abused substances including alcohol.